Short Interest in Esperion Therapeutics, Inc. (NASDAQ:ESPR) Decreases By 6.6%
Esperion Therapeutics, Inc. (NASDAQ:ESPR – Get Free Report) saw a large decline in short interest during the month of November. As of November 15th, there was short interest totalling 31,250,000 shares, a decline of 6.6% from the October 31st total of 33,460,000 shares. Based on an average daily volume of 3,820,000 shares, the days-to-cover ratio […]
More Stories
StockNews.com Initiates Coverage on Fuel Tech (NASDAQ:FTEK)
StockNews.com initiated coverage on shares of Fuel Tech (NASDAQ:FTEK – Free Report) in a research report released on Wednesday morning....
Remark (NASDAQ:MARK) Earns Sell Rating from Analysts at StockNews.com
StockNews.com initiated coverage on shares of Remark (NASDAQ:MARK – Free Report) in a report published on Wednesday morning. The firm...
Avinger (NASDAQ:AVGR) Now Covered by Analysts at StockNews.com
StockNews.com initiated coverage on shares of Avinger (NASDAQ:AVGR – Free Report) in a research note released on Wednesday. The brokerage...
Cytosorbents (NASDAQ:CTSO) Earns Hold Rating from Analysts at StockNews.com
StockNews.com assumed coverage on shares of Cytosorbents (NASDAQ:CTSO – Free Report) in a research note issued to investors on Wednesday...
comScore (NASDAQ:SCOR) Earns Buy Rating from Analysts at StockNews.com
StockNews.com assumed coverage on shares of comScore (NASDAQ:SCOR – Free Report) in a report issued on Wednesday. The brokerage issued...
Ohio Valley Banc (NASDAQ:OVBC) Earns Hold Rating from Analysts at StockNews.com
StockNews.com started coverage on shares of Ohio Valley Banc (NASDAQ:OVBC – Free Report) in a research report sent to investors...